NCT05363761View on ClinicalTrials.gov

Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2029

Conditions
Diabetes Mellitus, Type 2Hypertension
Interventions
COMBINATION_PRODUCT

Neurotronic Infusion Catheter

Denervation of renal and common hepatic arteries by ethanol ablation with the Neurotronic Infusion Catheter

Trial Locations (3)

0816-03075

RECRUITING

Hospital Paitilla Clinicas y Hospitales, Panama City

Unknown

RECRUITING

Hospital Punta Pacifica, Panama City

RECRUITING

Sanatorio Adventista de Asunción, Asunción

Sponsors

Lead Sponsor

Neurotronic, Inc.

Collaborators (1)

Libra Medical
All Listed Sponsors
collaborator

Libra Medical

OTHER

lead

Neurotronic, Inc.

INDUSTRY